TAVI patients with coronary artery disease can derive benefits from percutaneous coronary intervention

Performing percutaneous coronary intervention (PCI) significantly improved outcomes in patients with stable coronary artery disease (CAD) and severe aortic stenosis selected for transcatheter aortic valve implantation (TAVI), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

Early Anti-TNF Reduces Perianal Fistula Risk in Kids With Crohn’s

LAS VEGAS — Children and teens with Crohn’s disease who received early tumor necrosis antagonist (anti-TNF) treatment had a lower risk of developing perianal fistulizing

January 29, 2024

Jazz Pharma’s Enrylaze wins European approval for AML and LBL – Pharmaceutical Technology

A 3D illustration showing abundant lymphoblasts in blood. Enrylaze, sold as RylaZe in the US and Canada, was approved by the US Food and Drug

September 22, 2023

Getting ahead of a non-alcoholic beverage boom among youths

The non-alcoholic beverage market is booming right now: zero-proof bottle shops and bars are popping up across the country; a non-alcoholic beer brand is even

June 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.